156
Participants
Start Date
April 30, 2024
Primary Completion Date
April 30, 2027
Study Completion Date
April 30, 2027
Nafamostat Mesylate
During RRT, a priming dose of 20 mg of nafamostat mesylate (NM) is administered before initiation of the procedure. Upon starting the machine, there is no loading dose, but a maintenance infusion rate of 25 mg/h of NM is maintained. NM is discontinued in the last half hour before the end of the RRT session.
Unfractionated Heparin
During RRT, a priming dose of 50 mg of unfractionated heparin (UFH) is administered before initiation of the procedure. Upon starting the machine, a loading dose of 0.2 mg/kg of UFH is given, followed by a maintenance infusion rate of 0.1 mg/kg/h of UFH. The anticoagulant is discontinued in the last half hour before the end of the RRT session.
Huashan Hospital, Fudan University, Shanghai
Shen Lei
OTHER